Literature DB >> 2997323

Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors.

H Salata, J M Cortés, R Enríquez de Salamanca, H Oliva, A Castro, E Kusak, V Carreño, C Hernandez Guío.   

Abstract

In order to assess the incidence of hepatocellular carcinoma (HCC) in porphyria cutanea tarda (PCT), 83 patients (77 males, 6 females, mean age 57.4 years) were studied. Thirteen patients (15.7%) had HCC, all of whom were male and cirrhotics with a mean age of 58.5 years. HCC patients showed a statistically significant (P less than 0.0005) longer evolution time (23 years since onset of the cutaneous disease) than patients without HCC (9.4 years), while the age of onset was similar in both groups. Differences in alcohol intake and hepatitis B virus (HBV) markers were non-significant, although high prevalence (54%) of past HBV infection was found in both groups. In HCC development, attributable risks of 100% were found for cirrhosis (P less than 0.001), male sex (P = NS) and for age over 51 (P less than 0.025). Therefore, PCT harbours a high incidence of HCC; evolution time, cirrhosis and age over 51 appear to be the most important contributing factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997323     DOI: 10.1016/s0168-8278(85)80746-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

Review 1.  Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.

Authors:  Saranya Chidambaranathan-Reghupaty; Paul B Fisher; Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2020-11-28       Impact factor: 6.242

Review 2.  Morphological and chemical mechanisms of elongated mineral particle toxicities.

Authors:  Ann E Aust; Philip M Cook; Ronald F Dodson
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

3.  Porphyrias, porphyrins and hepatocellular cancer.

Authors:  N O Bengtsson; L Hardell
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

Review 4.  The association between chemical-induced porphyria and hepatic cancer.

Authors:  Andrew G Smith; John R Foster
Journal:  Toxicol Res (Camb)       Date:  2018-06-01       Impact factor: 3.524

5.  Tandem Mass Tag-Based Proteomic Analysis of Potential Biomarkers for Hepatocellular Carcinoma Differentiation.

Authors:  Wei Wang; Qiang Li; Ge Huang; Bing-Yao Lin; Dongzi Lin; Yan Ma; Zhao Zhang; Tao Chen; Jie Zhou
Journal:  Onco Targets Ther       Date:  2021-02-12       Impact factor: 4.147

Review 6.  Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review.

Authors:  Daryl Ramai; Smit S Deliwala; Saurabh Chandan; Janice Lester; Jameel Singh; Jayanta Samanta; Sara di Nunzio; Fabio Perversi; Francesca Cappellini; Aashni Shah; Michele Ghidini; Rodolfo Sacco; Antonio Facciorusso; Luca Giacomelli
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

7.  Increased porphyrins in primary liver cancer mainly reflect a parallel liver disease.

Authors:  Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal:  Gastroenterol Res Pract       Date:  2009-10-18       Impact factor: 2.260

Review 8.  Update in global trends and aetiology of hepatocellular carcinoma.

Authors:  Prashanth Rawla; Tagore Sunkara; Pradhyumna Muralidharan; Jeffrey Pradeep Raj
Journal:  Contemp Oncol (Pozn)       Date:  2018-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.